Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Fulvestrant Mylan
(fulvestrant)
Uses, side effects, dosage information & price range
About this medicine
Fulvestrant is indicated for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women: not previously treated with endocrine therapy, or with disease relapse on or after adjuvant anti-estrogen therapy, or disease progression on antiestrogen therapy.
Common Brand Names for this Composition
The following popular commercial brand names contain fulvestrant as their active ingredient composition:
Fulvestrant Mylan
Mylan Pharmaceuticals Limited
Faslodex
AstraZeneca AB
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
fulvestrant
Category
Endocrine therapy
Manufacturer
Mylan Pharmaceuticals Limited
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.